Actionnariat et activité des initiés pour Autolus Therapeutics plc (AUTL): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.87 |
| Capitalisation | $498M |
| Bourse | NASDAQ |
| Pays | GB |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-01 | Piccina Cintia | M-Exempt | 20,000 | |
| 2026-09-01 | Piccina Cintia | M-Exempt | 20,000 | $47K |
| 2026-09-02 | Piccina Cintia | S-Sale | 6,713 | $16K |
| 2026-06-29 | YOUNG WILLIAM D | A-Award | 47,500 | $76K |
| 2026-06-29 | YOUNG WILLIAM D | A-Award | 31,667 | |
| 2026-06-29 | Rao Madduri Ravin | A-Award | 47,500 | $76K |
| 2026-06-29 | Rao Madduri Ravin | A-Award | 31,667 | |
| 2026-06-29 | Richardson Ryan | A-Award | 47,500 | $76K |
| 2026-06-29 | Richardson Ryan | A-Award | 31,667 | |
| 2026-06-29 | Leiderman Elisabeth | A-Award | 47,500 | $76K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $28.1M | $137.1M | $189.3M | $211.4M | $154.1M | $310.3M | $382.4M | $239.6M | $227.4M | $104.1M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $360.6M | $196.6M |
| Créances | $2.2M | $4.7M | $9.3M | $30.5M | $29.7M | $68000 | $29.0M | $1.0M | $48.2M | $75.8M |
| Stocks | 0 | 0 | $2.2M | 0 | 0 | 0 | 0 | 0 | $4.1M | $33.2M |
| Actifs Courants | $30.9M | $142.5M | $199.1M | $249.3M | $194.0M | $347.0M | $425.8M | $275.3M | $660.9M | $435.9M |
| Immobilisations Corporelles | $3.3M | $6.2M | $9.2M | $51.6M | $89.7M | $52.3M | $58.4M | $95.7M | $105.1M | $128.5M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | $9.5M | 0 | $9.3M | $254000 | $158000 | $65000 | 0 | 0 | $12.4M | $19.8M |
| Actifs Totaux | $34.2M | $148.7M | $217.7M | $303.5M | $294.2M | $405.6M | $490.3M | $375.4M | $782.7M | $589.1M |
| Dettes Fournisseurs | $1.4M | $1.9M | $3.0M | 0 | $2.3M | $431000 | $531000 | $103000 | $2.0M | $3.1M |
| Dette à Court Terme | 0 | 0 | 0 | $2.5M | $3.6M | 0 | 0 | 0 | 0 | $14.6M |
| Passifs Courants | $2.7M | $5.0M | $12.5M | $25.0M | $33.6M | $28.6M | $46.4M | $44.7M | $60.7M | $73.4M |
| Dette à Long Terme | 0 | 0 | $221000 | 0 | 0 | $47.0M | 0 | 0 | 0 | $270.2M |
| Passifs Totaux | $3.5M | $6.1M | $12.5M | $48.7M | $84.2M | $92.2M | $191.6M | $263.9M | $355.4M | $410.9M |
| Réserves | -$28.2M | -$47.9M | $163.8M | -$237.2M | -$379.2M | -$521.3M | -$670.2M | -$878.6M | -$1.10B | -$1.39B |
| Capitaux Propres | $30.7M | $142.6M | $205.1M | $254.8M | $210.0M | $313.3M | $298.7M | $111.5M | $427.3M | $178.1M |
| Dette Totale | $188000 | $265000 | $221000 | $26.2M | $54.2M | $68.0M | $24.3M | $53.0M | $52.6M | $351.6M |
| Dette Nette | -$27.9M | -$136.8M | -$189.1M | -$185.2M | -$99.9M | -$242.3M | -$358.2M | -$186.6M | -$535.4M | $50.9M |
| Fonds de Roulement | $28.2M | $137.4M | $186.6M | $224.3M | $160.3M | $318.4M | $379.4M | $230.6M | $600.2M | $362.5M |
Santé financière
| Dette / Capitaux propres | 1.12 |
| Ratio de liquidité | 4.89 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -3.23 |
Rentabilité
| Rentabilité des capitaux propres | -178.58% |
| Rentabilité du capital investi | -57.49% |
| Rentabilité des actifs | -56.77% |
| Marge brute | 15.66% |
| Marge opérationnelle | -210.76% |
| Marge nette | -238.62% |
Entreprises liées: ADCT · ANNX · AURA · BNTC · LBRX · NMRA · QSI
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de AUTL: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions